Skip to main content
European Commission logo print header

Peptide Dendrimers - A Chemical Platform for Functional Diversity

Ziel

Peptides have emerged as a therapeutically important class of drugs and offer the advantage of great specificity, potency and low toxicity. Short circulation half-life, poor proteolytic stability and bioavailability have however prevented them from becoming a mainstream source of drug candidates. Dendrimers are versatile, derivatizable, well-defined branched synthetic macromolecules with promising properties for a variety of applications in technology and medicine. Combining therapeutic peptides with dendrimers represents a promising approach to overcome bioavailability limitations, while at the same time introducing novel pharmacological and biophysical properties. The impact of the dendritic structure and multivalency on potency, selectivity, bioavailability and overall pharmacology will be studied on nicotinic acetylcholine and oxytocin/vasopressin G-protein coupled receptors, two important biomedical targets. A synthetic strategy based on efficient ligation chemistry and combinatorial assembly of building blocks will form the platform for the assembly of diverse multifunctional peptide dendrimers. These peptide dendrimers will undergo detailed structural, biophysical and pharmacological characterization for their use as diagnostic tools and therapeutics.

Aufforderung zur Vorschlagseinreichung

FP7-PEOPLE-2009-IOF
Andere Projekte für diesen Aufruf anzeigen

Koordinator

FUNDACIO INSTITUT DE RECERCA BIOMEDICA (IRB BARCELONA)
EU-Beitrag
€ 240 817,90
Adresse
CARRER BALDIRI REIXAC 10-12 PARC SCIENTIFIC DE BARCELONA
08028 Barcelona
Spanien

Auf der Karte ansehen

Region
Este Cataluña Barcelona
Aktivitätstyp
Research Organisations
Kontakt Verwaltung
Alexandre Puerto (Mr.)
Links
Gesamtkosten
Keine Daten